Prior to the discovery of Helicobacter pylori, peptic ulcer disease (PUD), which encompasses both gastric (GU) and duodenal (DU) ulcers, was believed to be due to gastric acid, the common dictum . Over recent decades, the incidence of PUD has decreased significantly, which is believed to be due to the decrease in H. pylori infection, particularly in developed countries
Prior to the discovery of Helicobacter pylori, peptic ulcer disease (PUD), which encompasses both gastric (GU) and duodenal (DU) ulcers, was believed to be due to gastric acid, the common dictum being 'No acid, no ulcer'. The discovery and initial isolation of Currently, extensive scientific evidence shows that the two major aetiological factors involved in PUD are infection with H. pylori and ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) 2, 3 .
Although gastric acid hyper-secretion is still considered to be a necessary factor, it is not a sufficient aetiological factor.
Each year PUD affects 4 million people worldwide with complications reported in 10-20% of these patients, and ulcer perforation in 2-14% of cases 4 . The annual incidence of PUD ranges 0.10-0.19%
and 0.03-0.17% for physician-diagnosed and in-hospital-diagnosed PUD, respectively 5 . Over recent decades, the incidence of PUD has decreased significantly, which is believed to be due to the decrease in H. pylori infection, particularly in developed countries 5 . Currently, GU is more commonly associated with use of NSAIDs, especially in older patients and those with comorbidities, in whom widespread prescription of NSAIDS and suboptimal adherence to gastroprotective therapy is common 6 .
Pathogenesis of peptic ulcer disease
Helicobacter pylori and peptic ulcer disease An important predisposing factor related to PUD is an individual's level of gastric acid secretion, as this determines the location of gastritis 7 . In subjects with reduced levels of gastric acid, a pangastritis results, which predisposes to GU, whereas in subjects in whom gastric acid secretion is increased, an antral-predominant gastritis develops, which predisposes to DU 7 . 1.41, 95% CI: 1.12-1.76, respectively). However, in both studies distinct geographical variations in the prevalence of the dupA gene, and the association between dupA and DU, were observed 13, 14 .
Given this, a recent study by Jung et al. 31 investigated if genetic differences in the makeup of the dupA gene may explain this disparity. In this study, the presence of a complete dupA cluster rather than dupA alone was found to be associated with the development of DU and increased IL-8 production, suggesting that the complete dupA cluster is required for full expression of this virulence factor 31 .
Nonsteroidal anti-inflammatory drugs and peptic ulcer disease 
Under the Microscope
NSAIDs have also been shown to increase the risk of PUD complications. For example, the use of low-dose acetylsialicylic acid (ASA) increases the risk of ulcer bleeding by 2-3-fold compared with nonusers 34 . This has been mainly attributed to ASA antiplatelet action on a pre-existing H. pylori-related ulcer, rather than its ulcerogenic effect as an NSAID 35 .
Other factors and peptic ulcer disease
It has been suggested that mucosal resistance to the effect of acid might be a key factor in PUD pathogenesis. For example, the presence or absence of protective substances in staple diets including certain phospholipids, sterols, and sterol ester fractions in lipids, which protect the gastric mucosa, has been related to geographical differences in the prevalence of duodenal ulceration 36 . These substances have been shown to exert protective activities against both gastric and duodenal ulceration, including NSAIDs-associated ulceration, and also promote healing of ulceration 36 .
Although smoking is not a primary cause of PUD, it has been reported to regulate aggressive and protective factors in the gastric mucosa, and therefore, it might be still considered an important contributor to the pathogenesis of PUD 37 .
Studies 
